Sort
21,453 grants matching “tuberculosis”
Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection
$193,752Tyler Steven Brown · Boston Medical Center · K08 · FY2023 · AI
Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection
$193,752Tyler Steven Brown · Boston Medical Center · K08 · FY2025 · AI
M. tuberculosis defenses against host oxidant systems.
$193,750University Of New Mexico · R01 · FY2003 · AI
Investigation of the Flavin Dependent Thymidylate Synthase enzyme as a potential antimicrobial target
$193,750Eric Michael Koehn · San Francisco State University · R16 · FY2024 · GM
Investigation of the Flavin Dependent Thymidylate Synthase enzyme as a potential antimicrobial target
$193,750Eric Michael Koehn · San Francisco State University · R16 · FY2025 · GM
Synthesis of Novel Bioactive Sphingolipids as a Resource
$193,750Robert Bittman · Queens College · R24 · FY2012 · HL
Synthesis of Novel Bioactive Sphingolipids as a Resource
$193,750Robert Bittman · Queens College · R24 · FY2013 · HL
Synthesis of Novel Bioactive Sphingolipids as a Resource
$193,750Robert Bittman · Queens College · R24 · FY2011 · HL
PPE Export by the Essential ESX-5 Secretion System in M. tuberculosis Virulence
$193,750Anna Degraff Tischler · University Of Minnesota · R21 · FY2022 · AI
B12 Autotrophy as a Virulence Mechanism in Infectious Leptospira
$193,750Michael A Matthias · University Of California, San Diego · R21 · FY2015 · AI
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion
$193,750Anna Degraff Tischler · University Of Minnesota · R21 · FY2022 · AI
Recombinant archaeal organelles of SIV and HIV antigens
$193,750University Of Massachusetts Amherst · R21 · FY2002 · AI
Analysis of host-derived nutrient utilization pathways in M. tuberculosis
$193,750Brian C Vanderven · Cornell University · R21 · FY2014 · AI
Development and Assessment of Video-Based Directly Observed Therapy for Tuberculosis
$193,724Sebastian Seiguer · Emocha Mobile Health, Inc. · R43 · FY2016 · MD
Role of LRRK2 in immunity in a nonhuman primate model of SIV
$193,707Krystal Vail · Tulane University Of Louisiana · K01 · FY2023 · OD
Soweto Syndemics: A Two-Phase Study of Surveillance and Co-Morbid Experiences
$193,576Emily A Mendenhall · Georgetown University · R21 · FY2018 · TW
A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis
$193,545Russell Ryan Kempker · Emory University · R21 · FY2017 · AI
Immunology Training Program-Predoctoral
$193,485Brian A Cobb · Case Western Reserve University · T32 · FY2019 · AI
Impact of HIV infection on early responses to TB exposure
$193,484Sara Auld · Emory University · K23 · FY2018 · AI
Studies of Mucosal Associated Invariant T (MAIT) cells in people with HIV, TB and HIV/TB co-infection in South Africa
$193,482Emily Beth Wong · Massachusetts General Hospital · K08 · FY2019 · AI
Genetic determinants of susceptibility to mycobacterial infections
$193,428Philippe Gros · Mcgill University · R01 · FY2014 · AI
Genetic determinants of susceptibility to mycobacterial infections
$193,428Philippe Gros · Mcgill University · R01 · FY2015 · AI
Genetic determinants of susceptibility to mycobacterial infections
$193,428Philippe Gros · Mcgill University · R01 · FY2012 · AI
Riboflavin biosynthesis and utilization in Mycobacterium tuberculosis
$193,394Jessica Chuang Seeliger · State University New York Stony Brook · R21 · FY2025 · AI
Identifying the drivers of ESX1 evolution in Mycobacterium tuberculosis
$193,375Sarah M Fortune · Harvard University D/B/A Harvard School Of Public Health · R21 · FY2025 · AI